Newsletter | April 30, 2021

04.30.21 -- No "Typical" Day For A Pharma CFO

Featured Articles
What Were Your Impressions Of Presenting At A Virtual JPM, And How Do You Think This Year’s Show Will Impact Future JPMs?

See the answer from Ron Cohen, M.D., president, CEO, and founder of Acorda Therapeutics.

For Pharma CFOs, There Is No Typical Day

“We’ve had a pandemic. We’ve had social unrest. We’ve had numerous, unfounded legal allegations. There’s nothing in any transition manual to address any of that,” says J&J's CFO Joe Wolk. 

How Has The Pandemic Impacted You — And Your People?

Disruption of life routines by COVID-19 provide a CNS opportunity on multiple fronts. 

Web-Exclusive Content
Complying With Batch Release: Auditing Electronic Batch Records

This article presents some advice for auditing electronic batch records to assess their cGMP status. This is useful in the qualification stage and essential once the electronic record system is in operation.

Special Edition #1: Leadership During COVID-19 — A Biopharma CEO Roundtable

Five biopharmaceutical industry CEOs discuss the challenges their companies have faced, along with best practices implemented in managing through the COVID-19 chaos.

April 2021 Digital Edition

Inside you will find more on:

  • Industry Research
  • Hiring For Commercialization
  • CEO Corner
  • Pharma Exec Q&A

View the digital edition.

Contribute To Life Science Leader
Article Submission Guidelines

Think you have a good idea for an article that Life Science Leader readers would find valuable? Read these guidelines first before submitting your idea or your article to our editorial director.